MR
Martine A Rothblatt
Chairperson & CEO

Martine A Rothblatt insider trades: UNITED THERAPEUTICS (UTHR) stock buys and sales

Chairperson & CEO, UNITED THERAPEUTICS Last trade Nov 5, 2026 1,041 Form 4 filings
$858.8M
Sold, last 12 months
175 sales
$864K
Bought, last 12 months
1 buy
1,025
Open-market trades
since 2005
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Martine reports to the SEC

Open-market buys and sales

1,025 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026UTHR↓ Sell$4.3M
Nov 5, 2026UTHR↓ Sell$1.2M
Nov 4, 2026UTHR↓ Sell$4.7M
Nov 4, 2026UTHR↓ Sell$1.1M
Nov 3, 2026UTHR↓ Sell$5.7M
Nov 2, 2026UTHR↓ Sell$5.7M
Oct 30, 2026UTHR↓ Sell$5.7M
Oct 29, 2026UTHR↓ Sell$5.7M
Oct 28, 2026UTHR↓ Sell$5.6M
Oct 27, 2026UTHR↓ Sell$5.6M
Oct 26, 2026UTHR↓ Sell$5.6M
Oct 23, 2026UTHR↓ Sell$5.5M
Oct 22, 2026UTHR↓ Sell$5.5M
Oct 21, 2026UTHR↓ Sell$5.3M
Oct 20, 2026UTHR↓ Sell$5.3M
Oct 19, 2026UTHR↓ Sell$5.2M
Oct 16, 2026UTHR↓ Sell$5.1M
Oct 15, 2026UTHR↓ Sell$5.2M
Oct 14, 2026UTHR↓ Sell$5.1M
Oct 13, 2026UTHR↓ Sell$5.2M
Oct 12, 2026UTHR↓ Sell$5.2M
Oct 9, 2026UTHR↓ Sell$5.2M
Oct 8, 2026UTHR↓ Sell$5.1M
Oct 7, 2026UTHR↓ Sell$5.2M
Oct 6, 2026UTHR↓ Sell$5.1M
Oct 5, 2026UTHR↓ Sell$5.1M
Oct 2, 2026UTHR↓ Sell$5.2M
Oct 1, 2026UTHR↓ Sell$5.5M
Sep 30, 2026UTHR↓ Sell$3.9M
Sep 30, 2026UTHR↓ Sell$1.1M
Sep 29, 2026UTHR↓ Sell$4.5M
Sep 28, 2026UTHR↓ Sell$4.6M
Sep 25, 2026UTHR↓ Sell$4.5M
Sep 24, 2026UTHR↓ Sell$4.5M
Sep 23, 2026UTHR↓ Sell$4.7M
Sep 22, 2026UTHR↓ Sell$4.7M
Sep 21, 2026UTHR↓ Sell$4.7M
Sep 18, 2026UTHR↓ Sell$4.7M
Sep 17, 2026UTHR↓ Sell$4.7M
Sep 16, 2026UTHR↓ Sell$4.8M
Sep 15, 2026UTHR↓ Sell$4.8M
Sep 14, 2026UTHR↓ Sell$4.8M
Sep 11, 2026UTHR↓ Sell$4.8M
Sep 10, 2026UTHR↓ Sell$4.8M
Sep 4, 2026UTHR↓ Sell$4.6M
Sep 3, 2026UTHR↓ Sell$4.6M
Sep 2, 2026UTHR↓ Sell$4.7M
Sep 1, 2026UTHR↓ Sell$4.9M
Aug 31, 2026UTHR↓ Sell$4.9M
Aug 28, 2026UTHR↓ Sell$4.9M

The latest 1,000 of 1,025 trades can be shown here. Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UTHR insiders

Open-market trades in the last 12 months

About Martine A Rothblatt's insider trades

Martine A Rothblatt is Chairperson & CEO at UNITED THERAPEUTICS (UTHR). Since Jan 12, 2005, Martine has reported 20 open-market purchases worth $14.5M and 1,005 sales worth $1.85B on SEC Form 4. In the last 12 months: 1 buy ($864K) and 175 sales ($858.8M).

233 sales (7% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (922 filings), grants and awards (18 filings), gifts (18 filings), shares returned to the company (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.